Vaccination coverage against three viral sexually transmitted diseases, among 18-to-30-year-olds seen between May 2023 and May 2024 in the Martinique University Hospital CeGIDD - 29/04/25
Editor: Pr. J-P Jean-Paul Stahl
Highlights |
• | In a young CeGIDD population, 59% of patients were HBV-immune at first visit. |
• | Among MSM, bisexual men and transgender people, 17% were HAV-immune, a proportion rising to 40% at the end of the study period. |
• | Among PrEP patients, 18% were HAV-immune, while 64% were HBV-immune. |
• | HPV vaccination was given to 12% of women, 13% of men, 37% of MSM, bisexual men and transgender patients, and to 41% of PrEP users. |
• | Efforts are needed from all health care providers to better protect these high-risk populations. |
Abstract |
Objective and Methods |
: We retrospectively assessed protection against HBV (defined by HBs Ab > 10 UI/L), HAV (defined by positive IgG), and HPV (defined by at least one shot) in 1161 patients aged 18–––30 years old who consulted at an HIV and STI screening center (CeGIDD) between May 2023 and May 2024. Results are presented by gender, sexual orientation and PrEP use.
Results |
All in all, 59% (621/1051) of the population was HBV-immune. Among MSM, bisexual men and transgender people, 17% (18/105) were HAV-immune, a proportion rising to 40% (42/105) at the end of the study period. Among PrEP patients, 18% (13/78) were HAV-immune and 64% (50/78) were HBV-immune. HPV vaccination was given to 12% (68/569) of women, 13% (72/583) of men, 37% (54/147) of MSM, bisexual men and transgender patients, and to 41% (32/78) of PrEP users.
Conclusion |
All health workers should be fully aware of the relevant recommendations and actively involved in enhancing patient protection.
Le texte complet de cet article est disponible en PDF.Keywords : Caribbean islands, HAV, HBV, HPV, Vaccines
Plan
Vol 55 - N° 3
Article 105055- mai 2025 Retour au numéro
Article précédent
- The neutrophil-to-lymphocyte ratio in bronchoalveolar lavage fluid could help to personalize corticosteroid therapy in severe COVID-19 pneumonia
- Nausicaa Beaudequin, Benjamin Glemain, Anne Fajac, Vincent Rothstein, Muriel Fartoukh, Guillaume Voiriot
- Infectious complications after autologous hematopoietic stem cell transplantation for patients with an autoimmune indication: A protocol for a systematic review and meta-analysis
- Carolin-Sophie Wagner, Alexander Lithopoulos, Risa Shorr, Harold Atkins
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?